Literature DB >> 18484565

HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.

Bahar Zarabi1, Anjan Nan, Jiachen Zhuo, Rao Gullapalli, Hamidreza Ghandehari.   

Abstract

This study describes the synthesis, characterization, and in vitro evaluation of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-gadolinium (Gd)-doxorubicin (Dox) conjugates. Copolymers of HPMA were derivatized to incorporate side chains for Gd chelation and Dox conjugation. The conjugates were characterized by their side chain contents, T(1) relaxivity (r(1)), stability, and in vitro cytotoxicity. High stability and relaxivity of these conjugates coupled with low toxicity show their potential for monitoring the in vivo fate of HPMA-based drug delivery systems by magnetic resonance imaging techniques.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484565      PMCID: PMC2704051          DOI: 10.1002/mabi.200700290

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  37 in total

1.  Approaches and agents for imaging the vascular system.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation.

Authors:  K Ulbrich; V Subr; J Strohalm; D Plocová; M Jelínková; B Ríhová
Journal:  J Control Release       Date:  2000-02-14       Impact factor: 9.776

3.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

Authors:  P Caravan; J J Ellison; T J McMurry; R B Lauffer
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

4.  Quantitative assays of the amount of diethylenetriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetry.

Authors:  S Gouin; F M Winnik
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

5.  Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.

Authors:  M Kissel; P Peschke; V Subr; K Ulbrich; J Schuhmacher; J Debus; E Friedrich
Journal:  PDA J Pharm Sci Technol       Date:  2001 May-Jun

6.  The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities.

Authors:  P Caravan; M T Greenfield; X Li; A D Sherry
Journal:  Inorg Chem       Date:  2001-12-17       Impact factor: 5.165

Review 7.  HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action.

Authors:  J Kopecek; P Kopecková; T Minko; Z Lu
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

8.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.

Authors:  R Weissleder; C H Tung; U Mahmood; A Bogdanov
Journal:  Nat Biotechnol       Date:  1999-04       Impact factor: 54.908

Review 9.  The dawning era of polymer therapeutics.

Authors:  Ruth Duncan
Journal:  Nat Rev Drug Discov       Date:  2003-05       Impact factor: 84.694

Review 10.  Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

Authors:  H Maeda; L W Seymour; Y Miyamoto
Journal:  Bioconjug Chem       Date:  1992 Sep-Oct       Impact factor: 4.774

View more
  3 in total

1.  Metal-containing and related polymers for biomedical applications.

Authors:  Yi Yan; Jiuyang Zhang; Lixia Ren; Chuanbing Tang
Journal:  Chem Soc Rev       Date:  2016-02-24       Impact factor: 54.564

2.  Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.

Authors:  Bahar Zarabi; Mark P Borgman; Jiachen Zhuo; Rao Gullapalli; Hamidreza Ghandehari
Journal:  Pharm Res       Date:  2009-01-22       Impact factor: 4.200

Review 3.  Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis.

Authors:  Brian T Luk; Liangfang Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2014-07-22       Impact factor: 9.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.